Scream queen actress Tiffany Shepis will make an appearance at QuarantinedCon. Photo courtesy of Tiffany Shepis

Though states around the country— including Texas— have been slowly but surely been trying to reopen businesses and public places and so forth amid this global pandemic, there have been many events that are still cancelled and won't go down until sometime next year.

For those disappointed that Comicpalooza had to cancel its festivities this year, a new online convention is ready to sate your geeky thirst. On Saturday and Sunday, May 2 and 3, locals can go online and attend QuarantinedCon, a new pop-culture convention where guests can hang out with celebs, get items from vendors, and enjoy the same convention fun right in the comfort of their own home.

The con is mainly the brainchild of Dirk Strangely, a Las Vegas-born, Houston-based multimedia artist and frequent guest at comic-book conventions. He has built that convention over at his online platform known as ArtFarm.tv.

"It's something that me and a few people in my network have been building for about three years now," Strangely (government name: John Christopher Carson), tells CultureMap. "We've been helping artists manage their online business and offline business. But, when the pandemic hit, I realized the whole industry basically tanked, and all the people in my network have been wondering how they're gonna make a living… And my platform is the perfect place to have a convention.

So, what I did was put my network to use to get the word out to supply and provide people in my community and in my industry a means to continue business in a pop-culture convention industry."

This convention is a free-for-all in every sense of the term. People can check out everything from magicians to people doing balloon-animal tutorials to live concerts to watch parties over on Facebook — all for free. Strangely has already rounded up quite a collection of guests.

John Kassir, who voiced the Crypt Keeper from HBO's Tales from the Crypt, will be in the house, along with horror icon Kane Hodder (who has played Jason in many a Friday the 13th movie) and Deadwood cast members Peter Jason, Larry Cedar, and Pasha D. Lychnikoff, among others.

"Once I started getting some of them set up," says Strangely, "word of mouth started spreading like wildfire. And even with the celebrities, when I got one of them, they would tell their friends that they're doing it, and their friends — obviously they're gonna have other celebrity friends. So, they tell their friends and their friends are calling me like, 'Hey, I'd love to be part of this too.'"

Strangely is hoping that this online convention will entice other well-known conventions to hit him and his platform up about doing online extensions of their conventions that people all over the world can attend.

"Conventions are a huge part of our industry and, yes, we're helping all the people who go to conventions," he says. "But what about the actual conventions themselves. We are going to help them do their own virtual, online conventions and provide a full-blown experience like they provide physically. And, if we do go back to gathering again soon, we're also gonna do it to supplement their convention. So, they're not limited to who can come to their convention geographically."

For more info on QuarantinedCon, visit the official site.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.